Abstract
Background
Pain is the most common discomfort experienced by children with cancer and occurs in almost 89% of patients in an advanced stage of the disease. It is most often not adequately treated because of inexperience and unfounded fears of analgesic treatment. In adults, patient controlled analgesia (PCA) is widely administered, while in children with moderate to severe cancer pain its use is still under evaluation for safety and efficacy.
Goals of work
To evaluate the efficacy and safety of fentanyl administered by PCA in children with cancer pain.
Materials and methods
Eighteen children (range 6 to 15 years) with moderate to severe pain were enrolled and treated with fentanyl by PCA plus background infusion (BI) (BI of 1 μg/kg/h with booster doses of 1 μg/kg by intravenous route). To evaluate efficacy and safety of the analgesic treatment, different subjective and objective parameters were monitored at 4-h intervals. In addition, patients’ satisfaction was assessed by a questionnaire at the end of the treatment.
Main results
All children experienced a good degree of analgesia and did not require any other analgesic drug during the treatment. Both subjective and objective parameters improved after starting pain-relieving treatment and no major side effects occurred. The questionnaire administered to the children showed a high grade of satisfaction.
Conclusions
PCA plus BI with fentanyl administered by intravenous route is a safe and efficacious method for analgesia in children with moderate to severe cancer pain. Our policy of fentanyl-treatment did not show any major side effects.
References
Berde CB, Lehn BM, Yee JD, Sethna NF, Russo D (1991) Patient-controlled analgesia in children and adolescents: a randomized, prospective comparison with intramuscular administration of morphine for postoperative analgesia. J Pediatr 118:460–466
Bray RJ, Woodhams AM, Vallis CJ, Kelly PJ, Ward-Platt MP (1996) A double-blind comparison of morphine infusion and patient controlled analgesia in children. Paediatr Anaesth 6:121–127
Coda BA, O’Sullivan S, Donaldson G, Bohl S, Chapman CR, Shen DD (1997) Comparative efficacy of patient-controlled administration of morphine, hydromorphone, or sufentanil for the treatment of oral mucositis pain following bone marrow transplantation. Pain 72:333–346
Dunbar PJ, Buckley P, Gavrin JR, Sanders JE, Chapman CR (1995) Use of patient-controlled analgesia for pain control for children receiving bone marrow transplant. J Pain Symptom Manage 10:604–611
Gaukroger PB, Chapman MJ, Davey RB (1991) Pain control in paediatric burns—the use of patient controlled analgesia. Burns 17:396–399
Lehmann KA (2005) Recent developments in patient-controlled analgesia. J Pain Symptom Manage 29:S72–S89
Mackie AM, Coda BC, Hill HF (1991) Adolescents use patient-controlled analgesia effectively for relief from prolonged oropharyngeal mucositis pain. Pain 46:265–269
Owen H, Mather LE, Runciman WB, Carapetis RJ, Upton RN (1987) The lockout interval in patient-controlled analgesia: a rational basis for choice? Br J Anaesth 59:1328–1329
Owen H, Plummer JL, Armstrong I, Mather LE, Cousins MJ (1989) Variables of patient controlled analgesia. 1. Bolus size. Anaesthesia 44:7–10
Peters JW, Bandel Hoekstra IE, Huijer Abu-Saad H, Bouwmeester J, Meursing AE, Tibboel D (1999) Patient controlled analgesia in children and adolescents: a randomized controlled trial. Paediatr Anaesth 9:235–241
Plummer JL, Owen H, Ilsley AH, Inglis S (1997) Morphine patient controlled analgesia is superior to meperidine patient-controlled analgesia for postoperative pain. Anesth Analg 84:794–799
Rodgers BM, Webb CJ, Stergios D, Newman BM (1988) Patient-controlled analgesia in pediatric surgery. J Pediatr Surg 23:259–262
Shapiro BS, Cohen DE, Howe CJ (1993) Patient-controlled analgesia for sickle-cell-related pain. J Pain Symptom Manage 8:22–28
Sidebotham D, Dijkhuizen MR, Schug SA (1997) The safety and utilization of patient-controlled analgesia. J Pain Symptom Manage 14:202–209
Sirkia K, Hovi L, Pouttu J, Saarinen-Pihkala UM (1998) Pain medication during terminal care of children with cancer. J Pain Symptom Manage 15:220–226
Tobias JD, Baker DK (1991) Patient controlled analgesia with fentanyl in children. Clin Pediatr 31:177–179
Trentadue NO, Kachoyeanos MK, Lea G (1998) A comparison of two regimens of patient-controlled analgesia for children with sickle cell disease. J Pediatr Nurs 13:15–19
Tyler DC, Pomietto M, Womack W (1996) Variation in opioid use during PCA in adolescents. Paediatr Anaesth 6:33–38
Walco GA, Cassidy RC, Schechter NL (1994) Pain, hurt, and harm. The ethics of pain control in infants and children. N Engl J Med 331:541–544
Wong DL, Baker CM (1988) Pain and children: comparison of assessment scales. Pediatr Nurs 14:9–17
Yeh CH, Lin CF, Tsai JL, Lai YM, Ku HC (1999) Determinants of parental decisions on ‘drop out’ from cancer treatment for childhood cancer patients. J Adv Nurs 30:193–199
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ruggiero, A., Barone, G., Liotti, L. et al. Safety and efficacy of fentanyl administered by patient controlled analgesia in children with cancer pain. Support Care Cancer 15, 569–573 (2007). https://doi.org/10.1007/s00520-006-0193-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-006-0193-8